LinkBack URL
About LinkBacks
Reply With QuoteDespite all the rhetoric on various forums, it will all come down to the FDA - v. difficult to second guess them.
Will Hemispherx Biopharma (AMEX:HEB) Make The Cut? I Think So
Published on July 06, 2009
It has been over a month since the FDA last informed Hemispherx Biopharma (AMEX:HEB) “it may require up to 1-2 additional weeks” to make its decision on HEB’s drug Ampligen, a treatment for Chronic Fatigue Syndrome. So now investors are in this state of “limbo” and no one knows when the FDA will make their decision.
According to a conference call, Dr. Carter stated Ampligen has a 80% chance of approval and possibly higher since the drug is classified as a NMW (New Molecular Entity) for which no other treatments exists. Only time will tell, until then we continue to wait.
If Ampligen is approved this will be the first and only FDA approved treatment for CFS with a estimated market of about 4 Million people.
Let us know what you think about HEB on the FavStock.com stock forums. You will notice FavStocks.com stock market forums don't have the usual pumpers, spammers, and trolls.
Despite all the rhetoric on various forums, it will all come down to the FDA - v. difficult to second guess them.
Hemispherx Not Among 4 to Get H1N1 Flu Contracts
I saw lots of people make huge money from this stock. Even some of my friend bought this stock at price 50 cents and then make huge money. basically this encourage me start trade business.
Last edited by Canada; 07-17-2009 at 01:58 PM.
HEB was never in the hunt for Flu contractsOriginally Posted by mohseni63
"Wide diversification is only required when investors do not understand what they are doing." - Warren Buffett
heb/ Ampligen
although its been a while and many are running out of patience on ampligen but do have a belief that it will come to reality,an if approved this will be the first and only FDA approved treatment for CFS with an estimated market of about 4+ Million people!!!!!
As much as I hate to admit it, I think Adam Fuerstein is right about this one. I was way up until his article dropped the bottom out from under me. I had a stop set but it sold at 60 cents under my stop.............I WAS MAD!!!!!!!!! However, I think he is right and I don't think it will get approved and they need new management. That is why I haven/t bought back in.
Can anyone show me where Mr. Fuerstein has been wrong in a similar instance to his HEB rant?
I am hoping for the FDA approval soon. I am starting to lose my patience.
Woo HEB is now become a patience measuring tool for lots of investors. If you pass this exam this time may be you will have a bright future. Good luck guys.
Posting Permissions 